CAHIC(SH:600195) Shang Hai Zheng Quan Bao·2025-09-28 17:41Core Viewpoint - The company has approved several key resolutions during its board meeting, including the government acquisition of idle assets and the establishment of a high-end formulation production and R&D base, which are aimed at optimizing asset structure and enhancing operational efficiency [1][2][3][4][6][10]. Group 1: Government Acquisition of Idle Assets - The board approved the acquisition of idle assets from the Lanzhou Biological Pharmaceutical Factory and Lanzhou Zhongmu Pharmaceutical Technology Co., Ltd. by the Lanzhou Chengguan District People's Government, with a total compensation amount of 228.9782 million yuan [2][10][12]. - The assets being acquired include state-owned land, buildings, and equipment located at No. 2 Yanchang Road, Chengguan District, Lanzhou, which have been assessed as idle [10][12][32]. - The compensation amount is based on an evaluation report from Gansu Fangjia Real Estate Asset Appraisal Co., Ltd., with the land and buildings valued at 218.1045 million yuan and equipment at 10.8737 million yuan [12][20]. Group 2: High-end Formulation Production and R&D Base - The board approved the implementation of a high-end formulation production and R&D base project by its wholly-owned subsidiary, Zhongmu Nanjing Animal Pharmaceutical Co., Ltd., with a total planned investment of 299.6186 million yuan [3][6]. - The funding for the project will come from the subsidiary's own funds and self-raised funds, aimed at enhancing the company's product structure and promoting the development of its pet business [3][6]. Group 3: Governance and Management Updates - The board approved the revision of the Comprehensive Budget Management Measures, which aims to improve the company's financial management practices [4][5]. - The board also agreed to adjust the Strategic Committee to include ESG (Environmental, Social, and Governance) responsibilities, enhancing the company's governance structure and commitment to sustainable development [6][7]. - A new Market Value Management System was also approved to better manage the company's market capitalization [7].